Fabio Cataldi
Chief Medical Officer at Landos Biopharma, Inc. (LABP) since September 2022
Fabio Cataldi has filed 5 insider reports with the SEC since September 2022, as chief Medical Officer at Landos Biopharma, Inc. (LABP). The latest filing, on May 23, 2024, reports sale back to the company at Landos Biopharma, Inc. (LABP).
- Filings
- 5
- Companies
- 1
- Bought on market
- None
- Sold on market
- None
Companies where Fabio Cataldi is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Chief Medical Officersince September 2022 | May 23, 2024 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- May 23, 2024LABPSEC Form 4 filed by Cataldi FabioForm 4Sale back to the company
- Feb 29, 2024LABPSEC Form 4 filed by Cataldi FabioForm 4Grant or award
- Feb 28, 2023LABPSEC Form 4 filed by Cataldi FabioForm 4Grant or award
- Sep 5, 2022LABPSEC Form 4 filed by Cataldi FabioForm 4Grant or award
- Sep 5, 2022LABPFabio Cataldi became an insiderForm 3New insider
Compare Fabio Cataldi with
- Fabio Cataldi vs Fred Callori1 shared
- Fabio Cataldi vs Tiago Girao1 shared
- Fabio Cataldi vs Timothy M Mayleben1 shared
- Fabio Cataldi vs Roger Adsett1 shared
- Fabio Cataldi vs Alka Batycky1 shared
- Fabio Cataldi vs Christopher Nishan Garabedian1 shared
Questions about Fabio Cataldi
- What is Fabio Cataldi's role at Landos Biopharma, Inc.?
- Fabio Cataldi reports to the SEC as chief Medical Officer at Landos Biopharma, Inc. (LABP), according to the latest filing on May 23, 2024.
- Has Fabio Cataldi bought or sold stock recently?
- No open-market purchases or sales by Fabio Cataldi are on file. The filings report sale back to the company and grant or award.
- How do I get alerts when Fabio Cataldi files?
- Follow Fabio Cataldi on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Fabio Cataldi (SEC CIK 0001944447). Totals count each trade once, skipping amendments whose original is on file, from Sep 7, 2022 on. View on SEC EDGAR · Get this as JSON